• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非结直肠癌肝转移的手术治疗。

Surgical management of noncolorectal cancer liver metastases.

机构信息

Department of Surgery, Johns Hopkins Hospital, Baltimore, Maryland.

出版信息

Cancer. 2014 Oct 15;120(20):3111-21. doi: 10.1002/cncr.28743. Epub 2014 Jun 26.

DOI:10.1002/cncr.28743
PMID:24976177
Abstract

The number of hepatectomies performed for metastatic cancer has dramatically increased over the past 2 decades. Hepatectomy for stage IV colorectal cancer is now considered the standard of care for resectable patients with isolated hepatic disease and acceptable performance status. However, the indications for resection of noncolorectal origin liver metastases are not as clearly defined. This review focuses on emerging data for the resection of noncolorectal metastatic disease to the liver, with a focus on indications for surgical resection. Specifically, we review the current data on the surgical management of nonneuroendocrine and neuroendocrine tumors metastatic to the liver.

摘要

在过去的 20 年中,为转移性癌症进行的肝切除术数量显著增加。对于可切除的孤立性肝疾病和可接受的一般状况的 IV 期结直肠癌患者,肝切除术现在被认为是标准的治疗方法。然而,非结直肠癌肝转移灶切除的适应证并不明确。这篇综述重点介绍了非结直肠癌肝转移灶切除的新数据,重点关注手术切除的适应证。具体来说,我们回顾了目前关于非神经内分泌和神经内分泌肿瘤肝转移的手术治疗数据。

相似文献

1
Surgical management of noncolorectal cancer liver metastases.非结直肠癌肝转移的手术治疗。
Cancer. 2014 Oct 15;120(20):3111-21. doi: 10.1002/cncr.28743. Epub 2014 Jun 26.
2
Liver resection for noncolorectal, nonneuroendocrine metastases.非结直肠癌、非神经内分泌转移瘤的肝切除术
Acta Chir Belg. 2003 Oct;103(5):458-62. doi: 10.1080/00015458.2003.11679467.
3
Hepatic resection for noncolorectal nonneuroendocrine metastases.非结直肠癌非神经内分泌转移瘤的肝切除术
World J Surg. 1995 Jan-Feb;19(1):72-5. doi: 10.1007/BF00316982.
4
Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review.非结直肠癌原发性肿瘤肝转移灶切除术后的适应证及结果变化:一项单机构回顾研究
Ann Surg Oncol. 2005 Oct;12(10):778-85. doi: 10.1245/ASO.2005.11.018. Epub 2005 Aug 18.
5
Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis.非结直肠癌非神经内分泌性肝转移瘤的切除术:一项对比分析
J Am Coll Surg. 2007 Mar;204(3):372-82. doi: 10.1016/j.jamcollsurg.2006.12.019.
6
Hepatic surgery for metastases from neuroendocrine tumors.神经内分泌肿瘤肝转移的肝手术治疗
Surg Oncol Clin N Am. 2003 Jan;12(1):231-42. doi: 10.1016/s1055-3207(02)00076-5.
7
Controversies in defining prognostic relevant selection criteria that determine long-term effectiveness of liver resection for noncolorectal nonneuroendocrine liver metastasis.定义与预后相关的选择标准的争议,这些标准决定了肝切除术治疗非结直肠非神经内分泌肝转移的长期疗效。
Int J Surg. 2015 Dec;24(Pt A):85-90. doi: 10.1016/j.ijsu.2015.11.002. Epub 2015 Nov 14.
8
Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma.非结直肠癌、非神经内分泌癌转移灶的肝部分切除术。
Ann Surg. 2005 Feb;241(2):269-76. doi: 10.1097/01.sla.0000150244.72285.ad.
9
Hepatic resection of noncolorectal nonneuroendocrine metastases.非结直肠癌非神经内分泌转移瘤的肝切除术
Liver Transpl. 2000 Jan;6(1):97-101. doi: 10.1002/lt.500060114.
10
Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients.非结直肠癌原发性肝转移瘤切除术:基于147例单中心患者的指征与结果
J Am Coll Surg. 1998 Nov;187(5):487-93. doi: 10.1016/s1072-7515(98)00225-7.

引用本文的文献

1
Surgical results of liver metastases of tumors other than colorectal-neuroendocrine: Is it really worth it or is it necessary?结直肠癌-神经内分泌以外肿瘤肝转移的手术结果:真的值得做或有必要做吗?
Turk J Surg. 2024 Dec 27;40(4):267-274. doi: 10.47717/turkjsurg.2024.6474. eCollection 2024 Dec.
2
Essential updates 2021/2022: Surgical outcomes of oligometastasis in pancreatic ductal adenocarcinoma.2021/2022年重要更新:胰腺导管腺癌寡转移的手术结果
Ann Gastroenterol Surg. 2023 Jan 18;7(3):358-366. doi: 10.1002/ags3.12655. eCollection 2023 May.
3
Identifying Optimal Surgical Intervention-Based Chemotherapy for Gastric Cancer Patients With Liver Metastases.
确定针对伴有肝转移的胃癌患者的基于最佳手术干预的化疗方案。
Front Oncol. 2021 Nov 29;11:675870. doi: 10.3389/fonc.2021.675870. eCollection 2021.
4
Transarterial Radioembolization Agents: a Review of the Radionuclide Agents and the Carriers.经动脉放射性栓塞剂:放射性核素剂与载体的综述
Nucl Med Mol Imaging. 2021 Aug;55(4):162-172. doi: 10.1007/s13139-021-00709-3. Epub 2021 Jul 13.
5
Long-Term Survival of Two Patients with Liver Metastases from Advanced Gastric Cancer Treated with Radiofrequency Ablation and Chemotherapy.两名晚期胃癌肝转移患者接受射频消融和化疗后的长期生存情况
Case Rep Oncol. 2021 Feb 23;14(1):67-72. doi: 10.1159/000507849. eCollection 2021 Jan-Apr.
6
Surgery for Recurrent Pancreatic Cancer: Is It Effective?复发性胰腺癌手术:是否有效?
Cancers (Basel). 2019 Jul 16;11(7):991. doi: 10.3390/cancers11070991.
7
Transarterial Radioembolization (TARE) Agents beyond Y-Microspheres.经动脉放射性栓塞(TARE)药物除 Y 微球之外。
Biomed Res Int. 2018 Dec 31;2018:1435302. doi: 10.1155/2018/1435302. eCollection 2018.
8
A new risk score based on twelve hepatocellular carcinoma-specific gene expression can predict the patients' prognosis.一种基于12种肝细胞癌特异性基因表达的新风险评分能够预测患者的预后。
Aging (Albany NY). 2018 Sep 21;10(9):2480-2497. doi: 10.18632/aging.101563.
9
Contrast-enhanced ultrasound in liver cancer.肝癌的超声造影
Hepat Oncol. 2015 Jan;2(1):51-62. doi: 10.2217/hep.14.25. Epub 2015 Jan 12.
10
Treatment effect of conversion therapy and its correlation with VEGF expression in unresectable rectal cancer with liver metastasis.转化治疗对不可切除的伴有肝转移的直肠癌的疗效及其与VEGF表达的相关性
Oncol Lett. 2018 Jul;16(1):749-754. doi: 10.3892/ol.2018.8758. Epub 2018 May 21.